Lamosan
Lamosan is a Quito-based Ecuadorian pharmaceutical laboratory, founded in 1973, that manufactures and distributes oral health and family health medications under 16+ proprietary brands. It serves consumers via e-commerce and exports to Panama, Bolivia, Peru, and Colombia.
- Company typePrivate
- Founded1995
- HeadquartersQuito, Ecuador
- Headcount101–250
- GTM typeB2C
- OfferingHardware or Manufacturing
What Lamosan does
Lamosan Cía. Ltda. (legal name: Laboratorio Farmacéutico LAMOSAN CIA. LTDA.) is an Ecuadorian pharmaceutical laboratory founded in 1973 and headquartered in Quito, with a branch office in Guayaquil. The company manufactures and distributes pharmaceutical and dental medications for human use, operating two principal product categories: Oral Health (Salud Oral) and Family Health (Salud Familiar). The oral health portfolio spans 16+ proprietary sub-brands covering dental hygiene, orthodontic care, gum health, sensitivity relief, denture care, and bad breath, including the exclusive in-Ecuador distribution of Swiss premium brand Curaprox. The family health portfolio includes nasal saline products (Fisiol UB), baby care creams (CERO), feminine hygiene, antibiotics, antiparasitics, and wound care. The company has held Good Manufacturing Practices (BPM) certification since 1995 and employs 101–250 people.
The underlying technology is conventional pharmaceutical manufacturing supported by BPM-certified quality control systems, with no disclosed proprietary platform architecture or digital technology stack beyond a WordPress-based e-commerce storefront launched in late 2023. Lamosan generates revenue primarily through one-time product sales via two channels: a direct-to-consumer e-commerce platform (lamosan.com.ec) serving Ecuadorian end consumers, and direct export sales to four regional markets (Panama, Bolivia, Peru, and Colombia). The company also operates as a channel partner distributing international brands such as Curaprox within Ecuador. Pricing is at standard retail pharmaceutical levels and is not publicly disclosed. No institutional investors, private equity involvement, or public ownership is evidenced; the company appears independently owned under Ecuadorian Cía. Ltda. (limited liability company) law.
Lamosan firmographics
Firmographics- Name
- Lamosan
- Legal name
- Laboratorio Farmacéutico LAMOSAN CIA. LTDA.
- Website
- https://lamosan.com.ec
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Lamosan is a Quito-based Ecuadorian pharmaceutical laboratory, founded in 1973, that manufactures and distributes oral health and family health medications under 16+ proprietary brands. It serves consumers via e-commerce and exports to Panama, Bolivia, Peru, and Colombia.
- Ownership category
- akta.pro rank
Lamosan industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Dental Equipment and Supplies Manufacturing (339114), Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256), Toilet Preparation Manufacturing (32562), Medicinal and Botanical Manufacturing (325411)
- SIC
- Dental Equipment & Supplies (3843), Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Specialty Cleaning, Polishing And Sanitation Preparations (2842), Medicinal Chemicals & Botanical Products (2833)
- akta.pro industry
- Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening)Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)Toothbrushes (Manual)Dental Floss, Picks & Interdental CleanersFeminine Hygiene & Intimate Care (Wash, Wipes, Deodorants)Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Consumer Fragrances & Personal Care Manufacturing (Non-cosmetic)Medical & Hygiene Disposables (Underpads, Disposable Washcloths, Bed Bath Products)Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Paper Goods & Disposables (Tissue, Diapers, Feminine Care)
Keywords
Where Lamosan is headquartered
LocationHeadquarters
- HQ city
- Quito
- HQ country
- Ecuador
- HQ region
- Latin America
Offices2 records
Markets served
Lamosan business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Product Sales: Lamosan manufactures and sells pharmaceutical products including oral health and family health medications through their e-commerce platform and distribution network.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Lamosan product offering
Product offeringCore offering
Lamosan is an Ecuadorian pharmaceutical laboratory that manufactures and distributes odontological and family health medications, including oral care products (toothbrushes, toothpastes, mouthwashes, denture care, orthodontic care) and general health products (baby care, feminine hygiene, antibiotics, respiratory treatments, analgesics). The company operates its own manufacturing plant in Quito, distributes the international brand Curaprox in Ecuador, and exports its products to Panama, Bolivia, Peru, and Colombia.
Product overview
Lamosan is an Ecuadorian pharmaceutical laboratory operating two main product categories: Oral Health (Salud Oral) and Family Health (Salud Familiar). The oral health portfolio features the premium Curaprox brand with its signature Curen filament toothbrushes, along with specialized brands for orthodontic care (Ortodent), denture care (Denture, Dentafirme), gum health (Gingivit), dental sensitivity (Soral), and bad breath (Borosan). The family health line includes physiological saline products (Fisiol UB) for nasal hygiene, baby care creams (CERO), feminine hygiene (Ginecosan, Lactene), antibiotics (3-Micina, Cefulam), antiparasitics (Prothelmint), and wound care (Stratamed). The company also distributes international brands and exports medications to Panama, Bolivia, Peru, and Colombia.
Differentiator
Problem solved
Functional benefit
Brands
- Fisiol UB: Product line including isotonic and hypertonic saline solutions for nasal hygiene
- CERO
- Curaprox
- Topident
- Gingivit
- Denture
- Ortodent
- Soral
- Aquilea
- Dentafirme
- Borosan
- 3-Micina
- Ferro B
- Lamogrip
- Lamocox
- Prothelmint
- Bucagel
Products and services
- Curaprox Premium Swiss brand of oral hygiene products distributed in Ecuador by Lamosan, including toothbrushes, toothpastes, mouthwashes, interdental brushes, and specialty brushes for implants, orthodontics, kids, and babies. Targeted at consumers seeking high-quality oral care and at dental professionals.
- Fisiol UB Physiological saline solution products for nasal, ocular, and wound cleansing. Targeted at family use for daily hygiene and minor medical needs.
- CERO Baby care product line including items for infant hygiene and skincare. Targeted at parents and caregivers of infants.
- Topident Dental topical anesthetic and anti-inflammatory product used in dental procedures. Targeted at dental professionals and clinics.
- Gingivit Product line addressing gingivitis and gum-related conditions. Targeted at consumers with gum health concerns.
- Ortodent Orthodontic care products designed for patients with braces and other orthodontic appliances. Targeted at orthodontic patients.
- Denture Denture care product line for daily cleaning and maintenance of removable dental prostheses. Targeted at denture wearers.
- Soral Dental desensitizing products for relief of tooth sensitivity. Targeted at consumers with dental hypersensitivity.
- Borosan Oral hygiene products for bad breath (halitosis) elimination. Targeted at consumers seeking breath freshening solutions.
- Dentafirme Denture adhesive and fixing products providing secure hold for removable dental prostheses. Targeted at denture wearers.
- 3-Micina Azithromycin-based antibiotic for the treatment of bacterial infections. Targeted at consumers with physician-prescribed bacterial infections.
- Ferro B Iron and B-complex vitamin supplement for the prevention and treatment of iron-deficiency anemia. Targeted at consumers with anemia or nutritional deficiencies.
- Lamogrip Cold and respiratory symptom relief medication. Targeted at consumers with cold and flu symptoms.
- Lamocox Anti-inflammatory and analgesic medication for pain relief and inflammation reduction. Targeted at consumers with musculoskeletal pain and inflammation.
- Prothelmint Antiparasitic medication for the treatment of parasitic worm infections. Targeted at consumers with parasitic infections.
- Bucagel Oral antiseptic gel for the treatment of mouth ulcers and oral lesions. Targeted at consumers with oral mucosal conditions.
- Aquilea Colageno Collagen-based nutritional supplement for skin, joint, and bone health. Targeted at adults seeking nutritional supplementation.
- Stratamed Medical-grade silicone gel for the prevention and treatment of scars. Targeted at consumers with post-surgical or scar-related concerns.
- Cefulam Cefuroxime-based antibiotic medication for bacterial infections. Targeted at consumers with physician-prescribed bacterial infections.
- Atosyl Antitussive syrup for cough suppression. Targeted at consumers with cough symptoms.
- Ginecosan Feminine hygiene and intimate care product. Targeted at women seeking intimate hygiene solutions.
- Lactene Skin and nipple care product for breastfeeding mothers. Targeted at nursing mothers.
- Saliv Synthetic saliva substitute for dry mouth (xerostomia) relief. Targeted at consumers with reduced saliva production.
- Relevium Dentalac Probiotic oral supplement for oral microbiome balance and dental health. Targeted at consumers seeking preventive oral care.
- Odontoseptic Oral antiseptic solution for mouth disinfection and oral hygiene. Targeted at consumers with oral infections or post-procedure care.
- Curaprox BE YOU Premium whitening toothpaste with natural ingredients from the Curaprox brand line. Targeted at consumers seeking whitening and fresh breath.
- Curaprox Black is White Charcoal-based whitening toothpaste from the Curaprox line for stain removal and teeth whitening. Targeted at consumers seeking whitening solutions.
- Curaprox Implant Kit Specialized oral hygiene kit for dental implant maintenance, including specialty brushes and cleaning tools. Targeted at dental implant patients.
- Curaprox Surgical Post-surgical toothbrush designed for patients recovering from dental surgery. Targeted at post-surgical patients.
- Curaprox Kids Children's toothbrush line designed for kids' oral hygiene needs. Targeted at parents of young children.
- Curaprox Baby Baby toothbrush line for infant oral care. Targeted at parents of infants and toddlers.
- Dentek Dental Guard Night-time dental guard for the prevention of bruxism (teeth grinding) damage. Targeted at consumers with bruxism.
Companies that use Lamosan
Customer profileSegments2 records
Ideal customer profiles2 records
Lamosan technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Lamosan partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- CuraproxcoreLamosan represents and distributes Curaprox products in Ecuador. Curaprox is a Swiss brand specializing in oral health products including toothbrushes, interdental brushes, and dental floss with their proprietary Curen filaments.
- Pharmaceutical Export Partners (Panama, Bolivia, Peru, Colombia)minorLamosan exports medications to Panama, Bolivia, Peru, and Colombia as part of their regional expansion strategy.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Lamosan competitors and assessment
Company assessmentBroad incumbents
- Colgate-Palmolive: Global leader in oral care (toothpaste, toothbrushes, mouthwash) sold across Latin America including Ecuador. Broadly overlaps Lamosan's oral-care portfolio but at mass-market scale and price points, serving as the dominant competitive reference rather than a niche peer.
- Procter & Gamble (Oral Care): Multinational consumer-goods company with oral-care brands (Crest, Oral-B) sold across Latin America. Broad incumbent competitor to Lamosan's toothpaste, mouthwash, and toothbrush categories, though operating at mass-market scale rather than specialty niches.
- GSK Consumer Healthcare: Global OTC and oral-care player (Sensodyne, Aquafresh, parodontax) with strong Latin American distribution. Overlaps with Lamosan's Soral sensitivity line, Gingivit gum-health line, and broader OTC portfolio, but operates at global scale with much larger marketing budgets.
Direct peers
- Laboratorios Bagó: Argentina-based multinational pharmaceutical company with strong Andean and Latin American presence manufacturing OTCs, prescription drugs, and personal-care products. Comparable to Lamosan in both product categories (oral care, dermatology, OTC) and regional export footprint.
- Curaden (Curaprox): Swiss oral-care manufacturer of the Curaprox brand (toothbrushes, interdental brushes, dentifrices) which Lamosan distributes in Ecuador. Direct product overlap in premium toothbrushes, dental floss, and whitening — and the brand partner whose products populate Lamosan's premium oral-care category.
- Genomma Lab Internacional: Mexico-headquartered Latin American OTC and personal-care company selling pharmaceuticals, oral care, and family health products across Mexico and South America. Direct comparable in product categories (oral care, OTCs, baby/feminine care) and regional distribution footprint that overlaps Lamosan's export markets.
- Tecnoquímicas: Colombian pharmaceutical laboratory with broad OTC, oral care, and personal-care portfolio including the MK and Winthrop brands distributed across the Andean region. Directly comparable as a regional pharma manufacturer/distributor in the same geography (Colombia, Ecuador, Peru) where Lamosan exports.
- Unipharma (Grupo Unipharm): Ecuadorian pharmaceutical laboratory manufacturing and distributing OTC, personal-care, and oral-care products in the domestic Ecuadorian market. Most direct local peer — same headquarters geography, same domestic distribution channels, and same product categories as Lamosan.
Regional players
- Laboratorios Stein: Peruvian pharmaceutical laboratory manufacturing oral-care, dermatology, and OTC products for the Andean market. Comparable as a regional LatAm pharma manufacturer in similar product categories, though primarily Peru-focused rather than Ecuador-anchored like Lamosan.
- Laboratorios Andrómaco: Chile-based pharmaceutical laboratory with personal-care, dermatology, and OTC products distributed across Chile, Peru, and other Andean markets. Comparable in product categories and regional scope, though concentrated in Chile rather than Ecuador.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Lamosan social profiles
Digital presenceLamosan compliance and trust
Trust signalCompliance1 record
Lamosan financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lamosan leadership team
Management profileNumber of profiles
Lamosan funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lamosan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lamosan
What does Lamosan do?
Lamosan is an Ecuadorian pharmaceutical laboratory that manufactures and distributes odontological and family health medications, including oral care products (toothbrushes, toothpastes, mouthwashes, denture care, orthodontic care) and general health products (baby care, feminine hygiene, antibiotics, respiratory treatments, analgesics). The company operates its own manufacturing plant in Quito, distributes the international brand Curaprox in Ecuador, and exports its products to Panama, Bolivia, Peru, and Colombia.
Is Lamosan a public or private company?
Lamosan is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Lamosan founded?
Lamosan was founded in 1995. It employs 101 to 250 people.
Where is Lamosan based?
Lamosan is headquartered in Quito, Ecuador, in the Latin America region.
How does Lamosan make money?
One revenue line is on record: product Sales.
Who are Lamosan's main competitors?
Broad incumbents on record are Colgate-Palmolive, Procter & Gamble (Oral Care) and GSK Consumer Healthcare. Direct peers are Laboratorios Bagó, Curaden (Curaprox), Genomma Lab Internacional, Tecnoquímicas and Unipharma (Grupo Unipharm). Regional players are Laboratorios Stein and Laboratorios Andrómaco.
Does Lamosan have an API?
No public API is recorded for Lamosan.
What industry is Lamosan in?
Lamosan's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is CRADAMAA, Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening), with a secondary code of CRABAFAB, Toothbrushes (Manual). Its NAICS code is 339114 and its SIC code is 3843.